Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer

An abnormality in hedgehog (Hh) signaling has been implicated in the progression of prostate cancer (PCa) to a more aggressive and therapy-resistant disease. Our assessments of human PCa tissues have shown an overexpression of the Hh pathway molecules, glioma-associated oncogene homolog 1 (GLI-1), a...

Full description

Bibliographic Details
Main Authors: Santosh Kumar Singh, Jennifer B. Gordetsky, Sejong Bae, Edward P. Acosta, James W. Lillard, Rajesh Singh
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/9/1976
_version_ 1797555314578423808
author Santosh Kumar Singh
Jennifer B. Gordetsky
Sejong Bae
Edward P. Acosta
James W. Lillard
Rajesh Singh
author_facet Santosh Kumar Singh
Jennifer B. Gordetsky
Sejong Bae
Edward P. Acosta
James W. Lillard
Rajesh Singh
author_sort Santosh Kumar Singh
collection DOAJ
description An abnormality in hedgehog (Hh) signaling has been implicated in the progression of prostate cancer (PCa) to a more aggressive and therapy-resistant disease. Our assessments of human PCa tissues have shown an overexpression of the Hh pathway molecules, glioma-associated oncogene homolog 1 (GLI-1), and sonic hedgehog (SHH). The effect of the natural compound thymoquinone (TQ) in controlling the expression of Hh signaling molecules in PCa was investigated in this study. We generated planetary ball-milled nanoparticles (PBM-NPs) made with a natural polysaccharide, containing TQ, and coated with an RNA aptamer, A10, which binds to prostate-specific membrane antigen (PSMA). We prepared docetaxel-resistant C4-2B-R and LNCaP-R cells with a high expression of Hh, showing the integration of drug resistance and Hh signaling. Compared to free TQ, A10-TQ-PBM-NPs were more effective in controlling the Hh pathway. Our findings reveal an effective treatment strategy to inhibit the Hh signaling pathway, thereby suppressing PCa progression.
first_indexed 2024-03-10T16:45:40Z
format Article
id doaj.art-3fb34d388eef48e98475b8c555f3fc45
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T16:45:40Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-3fb34d388eef48e98475b8c555f3fc452023-11-20T11:35:41ZengMDPI AGCells2073-44092020-08-0199197610.3390/cells9091976Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate CancerSantosh Kumar Singh0Jennifer B. Gordetsky1Sejong Bae2Edward P. Acosta3James W. Lillard4Rajesh Singh5Department of Microbiology, Biochemistry and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USADepartments of Pathology and Urology, Vanderbilt University Medical Center, Nashville, TN 37232, USADivision of Preventive Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35205, USADepartment of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL 35294, USADepartment of Microbiology, Biochemistry and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USADepartment of Microbiology, Biochemistry and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USAAn abnormality in hedgehog (Hh) signaling has been implicated in the progression of prostate cancer (PCa) to a more aggressive and therapy-resistant disease. Our assessments of human PCa tissues have shown an overexpression of the Hh pathway molecules, glioma-associated oncogene homolog 1 (GLI-1), and sonic hedgehog (SHH). The effect of the natural compound thymoquinone (TQ) in controlling the expression of Hh signaling molecules in PCa was investigated in this study. We generated planetary ball-milled nanoparticles (PBM-NPs) made with a natural polysaccharide, containing TQ, and coated with an RNA aptamer, A10, which binds to prostate-specific membrane antigen (PSMA). We prepared docetaxel-resistant C4-2B-R and LNCaP-R cells with a high expression of Hh, showing the integration of drug resistance and Hh signaling. Compared to free TQ, A10-TQ-PBM-NPs were more effective in controlling the Hh pathway. Our findings reveal an effective treatment strategy to inhibit the Hh signaling pathway, thereby suppressing PCa progression.https://www.mdpi.com/2073-4409/9/9/1976prostate cancerthymoquinonedrug transporternanoparticlesaptamer
spellingShingle Santosh Kumar Singh
Jennifer B. Gordetsky
Sejong Bae
Edward P. Acosta
James W. Lillard
Rajesh Singh
Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
Cells
prostate cancer
thymoquinone
drug transporter
nanoparticles
aptamer
title Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
title_full Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
title_fullStr Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
title_full_unstemmed Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
title_short Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
title_sort selective targeting of the hedgehog signaling pathway by pbm nanoparticles in docetaxel resistant prostate cancer
topic prostate cancer
thymoquinone
drug transporter
nanoparticles
aptamer
url https://www.mdpi.com/2073-4409/9/9/1976
work_keys_str_mv AT santoshkumarsingh selectivetargetingofthehedgehogsignalingpathwaybypbmnanoparticlesindocetaxelresistantprostatecancer
AT jenniferbgordetsky selectivetargetingofthehedgehogsignalingpathwaybypbmnanoparticlesindocetaxelresistantprostatecancer
AT sejongbae selectivetargetingofthehedgehogsignalingpathwaybypbmnanoparticlesindocetaxelresistantprostatecancer
AT edwardpacosta selectivetargetingofthehedgehogsignalingpathwaybypbmnanoparticlesindocetaxelresistantprostatecancer
AT jameswlillard selectivetargetingofthehedgehogsignalingpathwaybypbmnanoparticlesindocetaxelresistantprostatecancer
AT rajeshsingh selectivetargetingofthehedgehogsignalingpathwaybypbmnanoparticlesindocetaxelresistantprostatecancer